BACKGROUND Metformin, an antidiabetic drug, decreases the incidence of various cancers in diabetic patients. Because endometrial cancer is associated with insulin resistance, the authors investigated whether a diabetes-therapeutic metformin dose inhibits cancer cell growth in patients with endometrial cancer.

READ FULL ARTICLE Curated publisher From Wiley Online Library